Edesa Biotech (NASDAQ:EDSA)

BRIEF

published on 06/24/2024 at 14:25, 5 months 27 days ago

BARDA sélectionne le médicament d'Edesa Biotech pour un essai sur plateforme financé par les États-Unis dans le SDRA général

Essai Clinique Edesa Biotechnologie SDRA BARDA Paridiprubart
BRIEF

published on 06/24/2024 at 14:25, 5 months 27 days ago

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

Clinical Trial Edesa Biotech ARDS BARDA Paridiprubart
PRESS RELEASE

published on 06/24/2024 at 14:20, 5 months 27 days ago

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
Edesa Biotech's paridiprubart selected for BARDA-funded Phase 2 trial to evaluate treatment for ARDS in hospitalized patients. Study to focus on threat-agnostic host-directed therapeutics

Edesa Biotech ARDS Phase 2 Trial Paridiprubart BARDA-funded
BRIEF

published on 05/10/2024 at 22:20, 7 months 10 days ago

Edesa Biotech publie ses résultats du 2e trimestre de l'exercice 2024

Performance Financière Edesa Biotechnologie Études Cliniques Résultats Trimestriels Fiscaux Traitement Du SDRA
BRIEF

published on 05/10/2024 at 22:20, 7 months 10 days ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

Financial Performance Edesa Biotech Clinical Studies Fiscal Quarterly Results ARDS Treatment
PRESS RELEASE

published on 05/10/2024 at 22:15, 7 months 10 days ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Edesa Biotech, Inc. reported financial results for the three and six months ended March 31, 2024, focusing on its Phase 3 ARDS study, EB05 drug candidate, and strategic plans for respiratory technology and dermatology. The company showcased operational efficiency and prudent capital management

Financial Results Edesa Biotech Inc Phase 3 ARDS Study EB05 Drug Candidate Respiratory Technology
BRIEF

published on 04/11/2024 at 15:05, 8 months 10 days ago

Edesa Biotech confirme sa participation à la conférence des investisseurs Bloom Burton Healthcare 2024

Biopharmaceutique Essais Cliniques Conférence Sur Les Soins De Santé Edesa Biotechnologie Maladies Immuno-inflammatoires
BRIEF

published on 04/11/2024 at 15:05, 8 months 10 days ago

Edesa Biotech Confirms Participation in 2024 Bloom Burton Healthcare Investor Conference

Immuno-inflammatory Diseases Clinical Trials Biopharmaceutical Edesa Biotech Healthcare Conference
PRESS RELEASE

published on 04/11/2024 at 15:00, 8 months 10 days ago

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Edesa Biotech, Inc. (NASDAQ:EDSA) to participate in Bloom Burton & Co. Healthcare Investor Conference, with CEO Par Nijhawan presenting. Company focuses on host-directed therapeutics for immuno-inflammatory diseases

Immuno-inflammatory Diseases EB05 Edesa Biotech NASDAQ:EDSA Bloom Burton & Co. Healthcare Investor Conference
BRIEF

published on 04/02/2024 at 15:05, 8 months 19 days ago

Edesa Biotech participera aux prochaines conférences d'investisseurs

Immunothérapie Essais Cliniques Produits Biopharmaceutiques Edesa Biotechnologie Conférences Investisseurs

1 2 ... 5

Published on 12/21/2024 at 01:30, 17 hours 27 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 27 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 52 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 57 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 27 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 6 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 12 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 46 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 39 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 39 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News